PASSIVE ENHANCEMENT OF RAT RENAL ALLOGRAFTS USING MOUSE MONOCLONAL XENOANTIBODIES
- 1 November 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 32 (5), 431-436
- https://doi.org/10.1097/00007890-198111000-00019
Abstract
The effectiveness for passive enhancement of rat renal allografts of mouse monoclonal xenoantibodies to rat major histocompatibility complex (MHC) antigens was studied. Two fully characterized, noncytotoxic monoclonal antibodies, both of which show some allospecificity, were tested in several different MHC-incompatible strain combinations chosen such that the monoclonal antibodies reacted with the donor but not the recipient strain. The antibody F21-105-1, directed at RT1-A (class I) antigens, interacts with all strains tested except the PVG/c strain and was tested in the LEW to PVG/c and WAG to PVG/c combinations. The antibody F17-23-2, directed at RT1-B (class II or Ia) antigens, interacts with all strains tested except the PVG/c, AUG, and WAG strains and was tested in the LEW to PVG/c and LEW to WAG combinations. Noncytotoxic monoclonal xenoantibodies are effective for passive enhancement, but in strong donor-recipient combinations they might not be as effective as conventional allosera. They may be useful reagents for testing the efficacy of passive enhancement in the clinical situation.This publication has 4 references indexed in Scilit:
- Endogenously produced Ia antigens within cells of convoluted tubules of rat kidney.The Journal of Immunology, 1981
- Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.Proceedings of the National Academy of Sciences, 1980
- COMBINED USE OF ANTI-LYMPHOCYTE SERUM AND CYCLOPHOSPHAMIDE TO SUPPRESS RENAL-ALLOGRAFT REJECTION IN THE RAT1979
- RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCHThe Lancet, 1977